AWM
WST icon

Avior Wealth Management’s West Pharmaceutical WST Stock Holding History

Avior Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$641K Hold
1,729
– – 0.02% 460
2026
Q2 		$621K Hold
1,729
– – 0.02% 464
2026
Q1 		$433K Sell
1,729
-1
-0.1% -$249 0.01% 566
2025
Q4 		$476K Hold
1,730
– – 0.01% 475
2025
Q3 		$454K Buy
+1,730
New +$420K 0.01% 473
2025
Q1 		– Sell
-622
Closed -$204K – 2351
2024
Q4 		$204K Sell
622
-85
-12% -$26.8K 0.01% 695
2024
Q3 		$212K Hold
707
– – 0.01% 678
2024
Q2 		$233K Sell
707
-242
-26% -$85.5K 0.01% 637
2024
Q1 		$376K Buy
949
+851
+868% +$315K 0.02% 523
2023
Q4 		$34.5K Sell
98
-1,844
-95% -$653K ﹤0.01% 797
2023
Q3 		$729K Buy
1,942
+1,780
+1,099% +$688K 0.05% 249
2023
Q2 		$62K Buy
162
+14
+9% +$5K ﹤0.01% 718
2023
Q1 		$51.3K Buy
+148
New +$43.2K ﹤0.01% 762
2022
Q1 		– Sell
-13
Closed -$6K – 1253
2021
Q4 		$6K Buy
13
+10
+333% +$4.3K ﹤0.01% 872
2021
Q3 		$1K Buy
+3
New +$1.26K ﹤0.01% 1036

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return

Avior Wealth Management's WST Position: Q3 2026 in Review

Avior Wealth Management held its West Pharmaceutical (WST) position steady in Q3 2026 at 1,729 shares worth $641K. The position accounts for 0.02% of the portfolio, ranked #460.

Avior Wealth Management first reported a position in WST in Q3 2021 and has held it in 15 quarters since. The position peaked at $729K in Q3 2023. 54 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Avior Wealth Management held 1,729 shares of West Pharmaceutical worth $641K as of Q3 2026.
  • Avior Wealth Management left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.02% of Avior Wealth Management's portfolio in Q3 2026, its #460 holding.
  • Avior Wealth Management first reported a position in West Pharmaceutical in Q3 2021 and has held it in 15 quarters since.
  • Avior Wealth Management's West Pharmaceutical position peaked at $729K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Avior Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.